Sulfonamides in   United States

Overview In February 2024 United States' Sulfonamides exports accounted up to $8.57M and imports accounted up to $192M, resulting in a negative trade balance of $183M. Between February 2023 and February 2024 the exports of United States'   Sulfonamides have decreased by $-30.3M (-78%) from $38.9M to $8.57M, while imports increased by $81.6M (74.1%) from $110M to $192M.

Destinations In February 2024, Sulfonamides were exported mostly to Netherlands ($3.89M), Japan ($1.89M), Germany ($682k), United Kingdom ($562k), and South Korea ($357k), and were imported mostly from Singapore ($122M), Ireland ($42.2M), India ($9.25M), Belgium ($6.22M), and China ($4.49M).

Growth In February 2024, the decrease in Sulfonamides's year-by-year exports was explained primarily by a decrease in exports to Saudi Arabia ($-70.7k or -96.5%), Chile ($-44.2k or -84.6%), and Guatemala ($-14.1k or -84.2%). In February 2024, the increase in Sulfonamides's year-by-year imports was explained primarily by an increase in imports from China ($16.9M or 62.4%), India ($2.82M or 16.2%), and Ireland ($2.6M or 15%).